Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea

References

• Tkac J, Man SF, Sin DD. Systemic consequences of COPD. Ther Adv Respir Dis. 2007;1(1):47–59. doi:10.1177/175346580708237419124347
   PubMedGoogle Scholar
• Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–773. doi:10.1016/S0140-6736(07)61380-417765526
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):258–266; discussion 290–251. doi:10.1513/pats.200504-045SR
   Google Scholar
• Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580. doi:10.1136/thx.2003.01958815223864
   PubMed Web of Science ®Google Scholar
• Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347–360.12608452
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Mullerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006;61(1):23–28. doi:10.1136/thx.2005.04220016143583
   PubMed Web of Science ®Google Scholar
• Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370(9589):797–799. doi:10.1016/S0140-6736(07)61383-X17765529
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Miravitlles M, Soriano JB, et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res. 2010;11:63. doi:10.1186/1465-9921-11-6220500811
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.0013380517138679
   PubMed Web of Science ®Google Scholar
• Eagan TM, Ueland T, Wagner PD, et al. Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort study. Eur Respir J. 2010;35(3):540–548. doi:10.1183/09031936.0008820919643942
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Lange P, Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(3):250–255. doi:10.1164/rccm.200605-713OC17053205
   PubMed Web of Science ®Google Scholar
• Shaaban R, Kony S, Driss F, et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med. 2006;100(12):2112–2120. doi:10.1016/j.rmed.2006.03.02716650972
   PubMed Web of Science ®Google Scholar
• Hancox RJ, Poulton R, Greene JM, et al. Systemic inflammation and lung function in young adults. Thorax. 2007;62(12):1064–1068. doi:10.1136/thx.2006.07687717604302
   PubMed Web of Science ®Google Scholar
• van Durme YM, Verhamme KM, Aarnoudse AJ, et al. C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):375–382. doi:10.1164/rccm.200810-1540OC19096002
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Zacho J, Lange P, Tybjaerg-Hansen A, Nordestgaard BG. C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax. 2011;66(3):197–204. doi:10.1136/thx.2009.13119321059738
   PubMed Web of Science ®Google Scholar
• Fogarty AW, Jones S, Britton JR, Lewis SA, McKeever TM. Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax. 2007;62(6):515–520. doi:10.1136/thx.2006.06696917251312
   PubMed Web of Science ®Google Scholar
• Jiang R, Burke GL, Enright PL, et al. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168(6):602–610. doi:10.1093/aje/kwn17418687665
   PubMed Web of Science ®Google Scholar
• Chang Y, Ryu S, Choi Y, et al. Metabolically healthy obesity and development of chronic kidney disease: a Cohort study. Ann Intern Med. 2016;164(5):305–312. doi:10.7326/M15-132326857595
   PubMed Web of Science ®Google Scholar
• Standardization of spirometry, 1994 update. American thoracic society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
   PubMed Web of Science ®Google Scholar
• Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175–2197. doi:10.1002/sim.120312210632
   PubMed Web of Science ®Google Scholar
• de Torres JP, Cordoba-Lanus E, Lopez-Aguilar C, et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J. 2006;27(5):902–907. doi:10.1183/09031936.06.0010960516455829
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bunjhoo H, Xiong W, Xu Y, Yang D. Association between C-reactive protein concentration and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Int Med Res. 2012;40(5):1629–1635. doi:10.1177/03000605120400050123206444
   PubMed Web of Science ®Google Scholar
• Rasmussen F, Mikkelsen D, Hancox RJ, et al. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J. 2009;33(2):382–388. doi:10.1183/09031936.0004070819010993
   PubMed Web of Science ®Google Scholar
• Kalhan R, Tran BT, Colangelo LA, et al. Systemic inflammation in young adults is associated with abnormal lung function in middle age. PLoS One. 2010;5(7):e11431. doi:10.1371/journal.pone.001143120625390
   PubMed Web of Science ®Google Scholar
• Hersh CP, Miller DT, Kwiatkowski DJ, Silverman EK. Genetic determinants of C-reactive protein in COPD. Eur Respir J. 2006;28(6):1156–1162. doi:10.1183/09031936.0014780516971405
   PubMed Web of Science ®Google Scholar
• Breyer MK, Spruit MA, Celis AP, et al. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Clin Nutr. 2009;28(6):642–647. doi:10.1016/j.clnu.2009.05.00519540024
   PubMed Web of Science ®Google Scholar
• Woloshin S, Schwartz LM. Distribution of C-reactive protein values in the United States. N Engl J Med. 2005;352(15):1611–1613. doi:10.1056/NEJM200504143521525
   PubMed Web of Science ®Google Scholar
• Agusti A. Systemic effects of chronic obstructive pulmonary disease: what we know and what we don’t know (but should). Proc Am Thorac Soc. 2007;4(7):522–525. doi:10.1513/pats.200701-004FM17878464
   PubMedGoogle Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.0012800819407051
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra04343015843671
   PubMed Web of Science ®Google Scholar
• Sevenoaks MJ, Stockley RA. Chronic obstructive pulmonary disease, inflammation and co-morbidity–a common inflammatory phenotype? Respir Res. 2006;7:70. doi:10.1186/1465-9921-7-7016669999
   PubMed Web of Science ®Google Scholar
• Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733–743. doi:10.1016/S0140-6736(09)61303-919716966
   PubMed Web of Science ®Google Scholar
• Eisner MD, Anthonisen N, Coultas D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693–718. doi:10.1164/rccm.200811-1757ST20802169
   PubMed Web of Science ®Google Scholar
• van Den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406. doi:10.1378/chest.09-262220348195
   PubMed Web of Science ®Google Scholar